SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies

• Tzu-Yuan Chao ,

  Roles Writing – original draft

  * E-mail: cchao@synermore.com

  Affiliation Synermore Biologics Co., Ltd., Taipei, Taiwan

  http://orcid.org/0000-0002-6781-7520

  ⨯
• Shiqi Ren,

  Roles Data curation, Investigation

  Affiliation Synermore Biologics Co., Ltd., Taipei, Taiwan

  ⨯
• Enyun Shen,

  Roles Methodology, Project administration

  Affiliation Beijing Cotimes Biotech Co., Ltd., Beijing, China

  ⨯
• Susan Moore,

  Roles Investigation, Methodology

  Affiliation Kansas State University Rabies Laboratory, Manhattan, Kansas State, United States of America

  ⨯
• Shou-feng Zhang,

  Roles Investigation, Methodology, Resources

  Affiliation Laboratory of Epidemiology and Key Laboratory of Jilin Provincial Zoonosis Control and Prevention, Military Veterinary Research Institute, Academy of Military Medical Sciences, Changchun, China

  ⨯
• Li Chen,

  Roles Writing – review & editing

  Affiliation Synermore Biologics Co., Ltd., Taipei, Taiwan

  ⨯
• Charles E. Rupprecht,

  Roles Methodology, Writing – review & editing

  Affiliation LYSSA LLC, Atlanta, Georgia, United States of America

  ⨯
• Eric Tsao

  Roles Funding acquisition, Supervision

  Affiliation Synermore Biologics Co., Ltd., Taipei, Taiwan

  ⨯